Vicente-zurdo D, Rosales-conrado N, León-gonzález ME, Brunetti L, Piemontese L, Pereira-santos AR, Cardoso SM, Madrid Y, Chaves S, Santos MA. Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines 2022;10:1510. [DOI: 10.3390/biomedicines10071510][Cited by in Crossref: 1][Cited by in F6Publishing: 1][Article Influence: 1.0][Reference Citation Analysis]
Number
Citing Articles
1
Reiland KM, Eckroat TJ. Selective butyrylcholinesterase inhibition by isatin dimers and 3-indolyl-3-hydroxy-2-oxindole dimers. Bioorganic & Medicinal Chemistry Letters 2022;77:129037. [DOI: 10.1016/j.bmcl.2022.129037][Reference Citation Analysis]